Journey Medical: FDA Approval For Emrosi Makes This An Exciting Stock
The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.
JD Supra10d
FDA Releases Proposed Front-of-Package Nutrition Labeling Rule
On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...
The FDA's recall on certain Lay's potato chips escalates to worst risk category
A previous FDA recall on certain Lay's potato chip products has now been updated to the category with the highest risk for ...
Backdoor uncovered in China-made patient monitors — Contec CMS8000 raises questions about healthcare device security
The CISA and FDA have released security warnings about the Contec CMS8000, which is used for patient monitoring.
Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?
The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio ...
Buy Rating for Vertex Pharmaceuticals: FDA Approval of Journavx Boosts Market Potential and Stock Price Target
Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...
Positive Trial Data and FDA Prospects Drive Buy Rating for Artivion
Stifel Nicolaus analyst Rick Wise has maintained their bullish stance on AORT stock, giving a Buy rating yesterday.Invest with Confidence: ...
The News Journal9d
The FDA's recall on certain Lay's potato chips escalates to worst risk category
The FDA reports that these products were available ... you should not consume a Lay’s bag of chips matching the item recall description. Frito-Lay advises all who are at risk to discard the ...
Taste of Country on MSN13d
Warning! FDA Issues Urgent Recall on a Shocking Amount of Milk
The FDA has issued a major recall of around 20,000 cases of milk that were packaged and sold in America. According to ...
Ketamine-derived nasal spray treating Phoenix patients with severe depression
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...
Cortigent, Inc. (CRTG) Plans to Raise $15 Million in February 14th IPO
Cortigent, Inc. (CRTG) expects to raise $15 million in an initial public offering (IPO) on Friday, February 14th, IPO Scoop reports. The company will be issuing 1,500,000 shares at $10.00 per share.